Other Clinical Trials
CADENCE Clinical Trial
Cold agglutinin disease (CAD) is a rare type of autoimmune hemolytic anemia
in which the body’s immune system mistakenly attacks and destroys
its own red blood cells. The aim of this registry is to collect data to
better understand patient and clinical characteristics, disease progression,
complications, treatment impact, and patient-reported outcomes. This registry
will also improve the understanding of the natural history of CAD and
will help raise awareness of CAD and its treatment.
For more information, call (225) 237-1673.